Other Species / Isoforms
  ADD3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S3
_____MSSDASQGVI
0 1
ADD3 (human) _____MSSDASQGVI S3
ADD3 iso2 (human) _____MSSDASQGVI S3
ADD3 (mouse) _____MSsDTSPAVV S3-p
ADD3 iso2 (mouse) _____MSSDTSPAVV S3
ADD3 (rat) _____MSSDSSQAVI S3
T12-p
ASQGVITtPPPPsMP
Upstream
0 15
Treatment
  • selumetinib
  • vemurafenib
ADD3 (human) ASQGVITtPPPPsMP T12-p
ADD3 iso2 (human) ASQGVITTPPPPSMP T12
ADD3 (mouse) TSPAVVTtPPPPSMP T12-p
ADD3 iso2 (mouse) TSPAVVTTPPPPSMP T12
ADD3 (rat) SSQAVITtPPPPSMP T12-p
S17-p
ITtPPPPsMPHkERY
0 1
ADD3 (human) ITtPPPPsMPHkERY S17-p
ADD3 iso2 (human) ITTPPPPSMPHKERY S17
ADD3 (mouse) VTtPPPPSMPHkERY S17
ADD3 iso2 (mouse) VTTPPPPSMPHKERY S17
ADD3 (rat) ITtPPPPSMPHKERY S17
K21-ub
PPPsMPHkERYFDrI
0 3
ADD3 (human) PPPsMPHkERYFDrI K21-ub
ADD3 iso2 (human) PPPSMPHKERYFDRI K21
ADD3 (mouse) PPPSMPHkERYFDRI K21-ub
ADD3 iso2 (mouse) PPPSMPHKERYFDRI K21
ADD3 (rat) PPPSMPHKERYFDRI K21
R27-m1
HkERYFDrINENDPE
0 1
ADD3 (human) HkERYFDrINENDPE R27-m1
ADD3 iso2 (human) HKERYFDRINENDPE R27
ADD3 (mouse) HkERYFDRINEsDPE R27
ADD3 iso2 (mouse) HKERYFDRINESDPE R27
ADD3 (rat) HKERYFDRINEsDPE R27
N31
YFDrINENDPEyIRE
0 3
ADD3 (human) YFDrINENDPEyIRE N31
ADD3 iso2 (human) YFDRINENDPEYIRE N31
ADD3 (mouse) YFDRINEsDPEYLRE S31-p
ADD3 iso2 (mouse) YFDRINESDPEYLRE S31
ADD3 (rat) YFDRINEsDPEYLRE S31-p
Y35-p
INENDPEyIRERNMs
0 188
ADD3 (human) INENDPEyIRERNMs Y35-p
ADD3 iso2 (human) INENDPEYIRERNMS Y35
ADD3 (mouse) INEsDPEYLRERNMs Y35
ADD3 iso2 (mouse) INESDPEYLRERNMS Y35
ADD3 (rat) INEsDPEYLRERNMs Y35
S42-p
yIRERNMsPDLRQDF
Upstream
0 39
Treatment
  • BI_4834
  • nocodazole
ADD3 (human) yIRERNMsPDLRQDF S42-p
ADD3 iso2 (human) YIRERNMSPDLRQDF S42
ADD3 (mouse) YLRERNMsPDLRQDF S42-p
ADD3 iso2 (mouse) YLRERNMSPDLRQDF S42
ADD3 (rat) YLRERNMsPDLREDF S42-p
T59-p
MEQRKRVtQILQsPA
0 1
ADD3 (human) MEQRKRVtQILQsPA T59-p
ADD3 iso2 (human) MEQRKRVTQILQSPA T59
ADD3 (mouse) MEQRKRVTQILQsPA T59
ADD3 iso2 (mouse) MEQRKRVTQILQSPA T59
ADD3 (rat) MEQRKRVTQILQSPA T59
S64-p
RVtQILQsPAFREDL
0 25
ADD3 (human) RVtQILQsPAFREDL S64-p
ADD3 iso2 (human) RVTQILQSPAFREDL S64
ADD3 (mouse) RVTQILQsPAFREDL S64-p
ADD3 iso2 (mouse) RVTQILQSPAFREDL S64
ADD3 (rat) RVTQILQSPAFREDL S64
R138
VKGEKLTRCKLASLY
0 2
ADD3 (human) VKGEKLTRCKLASLY R138
ADD3 iso2 (human) VKGEKLTRCKLASLY R138
ADD3 (mouse) VKGEKLTrCKLASLY R138-m1
ADD3 iso2 (mouse) VKGEKLTRCKLASLY R138
ADD3 (rat) VKGEKLTRCELASLY R138
K280-ub
EERIQLQkVLGPSCK
0 4
ADD3 (human) EERIQLQkVLGPSCK K280-ub
ADD3 iso2 (human) EERIQLQKVLGPSCK K280
ADD3 (mouse) EERIELQKVLGPSCK K280
ADD3 iso2 (mouse) EERIELQKVLGPSCK K280
ADD3 (rat) EERIELQKVLGPSCK K280
S360-p
GGGVNMGsHQKWKVG
0 1
ADD3 (human) GGGVNMGsHQKWKVG S360-p
ADD3 iso2 (human) GGGVNMGSHQKWKVG S360
ADD3 (mouse) GGGVNMASHQKWKVG S360
ADD3 iso2 (mouse) GGGVNMASHQKWKVG S360
ADD3 (rat) GGGVNMGSHQKWKVG S360
R376
IEFEGLMRTLDNLGy
0 1
ADD3 (human) IEFEGLMRTLDNLGy R376
ADD3 iso2 (human) IEFEGLMRTLDNLGY R376
ADD3 (mouse) IEFEGLMrTLDNLGY R376-m1
ADD3 iso2 (mouse) IEFEGLMRTLDNLGY R376
ADD3 (rat) IEFEGLMRTLDNLGY R376
Y383-p
RTLDNLGyRTGYAyr
Upstream
0 1
Treatment
  • nocodazole
ADD3 (human) RTLDNLGyRTGYAyr Y383-p
ADD3 iso2 (human) RTLDNLGYRTGYAYR Y383
ADD3 (mouse) rTLDNLGYrTGYAYR Y383
ADD3 iso2 (mouse) RTLDNLGYRTGYAYR Y383
ADD3 (rat) RTLDNLGYRTGYAYR Y383
R384
TLDNLGyRTGYAyrH
0 1
ADD3 (human) TLDNLGyRTGYAyrH R384
ADD3 iso2 (human) TLDNLGYRTGYAYRH R384
ADD3 (mouse) TLDNLGYrTGYAYRH R384-m1
ADD3 iso2 (mouse) TLDNLGYRTGYAYRH R384
ADD3 (rat) TLDNLGYRTGYAYRH R384
Y389-p
GyRTGYAyrHPLIRE
0 1
ADD3 (human) GyRTGYAyrHPLIRE Y389-p
ADD3 iso2 (human) GYRTGYAYRHPLIRE Y389
ADD3 (mouse) GYrTGYAYRHPLVRE Y389
ADD3 iso2 (mouse) GYRTGYAYRHPLVRE Y389
ADD3 (rat) GYRTGYAYRHPLVRE Y389
R390-m1
yRTGYAyrHPLIREK
0 1
ADD3 (human) yRTGYAyrHPLIREK R390-m1
ADD3 iso2 (human) YRTGYAYRHPLIREK R390
ADD3 (mouse) YrTGYAYRHPLVREK R390
ADD3 iso2 (mouse) YRTGYAYRHPLVREK R390
ADD3 (rat) YRTGYAYRHPLVREK R390
K401
IREKPRHKsDVEIPA
0 1
ADD3 (human) IREKPRHKsDVEIPA K401
ADD3 iso2 (human) IREKPRHKSDVEIPA K401
ADD3 (mouse) VREKPRHksDVEIPA K401-ub
ADD3 iso2 (mouse) VREKPRHKSDVEIPA K401
ADD3 (rat) VREKPRHKSDVEIPA K401
S402-p
REKPRHKsDVEIPAt
Upstream
0 22
Treatment
  • gefitinib
  • ischemia
  • nocodazole
ADD3 (human) REKPRHKsDVEIPAt S402-p
ADD3 iso2 (human) REKPRHKSDVEIPAT S402
ADD3 (mouse) REKPRHksDVEIPAT S402-p
ADD3 iso2 (mouse) REKPRHKSDVEIPAT S402
ADD3 (rat) REKPRHKSDVEIPAT S402
T409-p
sDVEIPAtVtAFsFE
0 2
ADD3 (human) sDVEIPAtVtAFsFE T409-p
ADD3 iso2 (human) SDVEIPATVTAFSFE T409
ADD3 (mouse) sDVEIPATVTAFsFE T409
ADD3 iso2 (mouse) SDVEIPATVTAFSFE T409
ADD3 (rat) SDVEIPATVTAFSFE T409
T411-p
VEIPAtVtAFsFEDD
0 1
ADD3 (human) VEIPAtVtAFsFEDD T411-p
ADD3 iso2 (human) VEIPATVTAFSFEDD T411
ADD3 (mouse) VEIPATVTAFsFEDD T411
ADD3 iso2 (mouse) VEIPATVTAFSFEDD T411
ADD3 (rat) VEIPATVTAFSFEDD T411
S414-p
PAtVtAFsFEDDtVP
0 7
ADD3 (human) PAtVtAFsFEDDtVP S414-p
ADD3 iso2 (human) PATVTAFSFEDDTVP S414
ADD3 (mouse) PATVTAFsFEDDSAP S414-p
ADD3 iso2 (mouse) PATVTAFSFEDDSAP S414
ADD3 (rat) PATVTAFSFEDDSVP S414
T419-p
AFsFEDDtVPLsPLk
0 1
ADD3 (human) AFsFEDDtVPLsPLk T419-p
ADD3 iso2 (human) AFSFEDDTVPLSPLK T419
ADD3 (mouse) AFsFEDDSAPLsPLk S419
ADD3 iso2 (mouse) AFSFEDDSAPLSPLK S419
ADD3 (rat) AFSFEDDSVPLsPLK S419
S423-p
EDDtVPLsPLkyMAQ
Upstream
1 44
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • ischemia
  • nocodazole
ADD3 (human) EDDtVPLsPLkyMAQ S423-p
ADD3 iso2 (human) EDDTVPLSPLKYMAQ S423
ADD3 (mouse) EDDSAPLsPLkFMAQ S423-p
ADD3 iso2 (mouse) EDDSAPLSPLKFMAQ S423
ADD3 (rat) EDDSVPLsPLKYMAQ S423-p
K426-ub
tVPLsPLkyMAQRQQ
0 3
ADD3 (human) tVPLsPLkyMAQRQQ K426-ub
ADD3 iso2 (human) TVPLSPLKYMAQRQQ K426
ADD3 (mouse) SAPLsPLkFMAQRQQ K426-ub
ADD3 iso2 (mouse) SAPLSPLKFMAQRQQ K426
ADD3 (rat) SVPLsPLKYMAQRQQ K426
Y427-p
VPLsPLkyMAQRQQR
0 1
ADD3 (human) VPLsPLkyMAQRQQR Y427-p
ADD3 iso2 (human) VPLSPLKYMAQRQQR Y427
ADD3 (mouse) APLsPLkFMAQRQQR F427
ADD3 iso2 (mouse) APLSPLKFMAQRQQR F427
ADD3 (rat) VPLsPLKYMAQRQQR Y427
K436-ac
AQRQQREkTRWLNsP
0 1
ADD3 (human) AQRQQREkTRWLNsP K436-ac
ADD3 iso2 (human) AQRQQREKTRWLNSP K436
ADD3 (mouse) AQRQQREKTRWLNsP K436
ADD3 iso2 (mouse) AQRQQREKTRWLNSP K436
ADD3 (rat) AQRQQREKTRWLNSP K436
S442-p
EkTRWLNsPNtyMkV
0 33
ADD3 (human) EkTRWLNsPNtyMkV S442-p
ADD3 iso2 (human) EKTRWLNSPNTYMKV S442
ADD3 (mouse) EKTRWLNsPNTyMKV S442-p
ADD3 iso2 (mouse) EKTRWLNSPNTYMKV S442
ADD3 (rat) EKTRWLNSPNTYMKV S442
T445-p
RWLNsPNtyMkVNVP
0 2
ADD3 (human) RWLNsPNtyMkVNVP T445-p
ADD3 iso2 (human) RWLNSPNTYMKVNVP T445
ADD3 (mouse) RWLNsPNTyMKVNVP T445
ADD3 iso2 (mouse) RWLNSPNTYMKVNVP T445
ADD3 (rat) RWLNSPNTYMKVNVP T445
Y446-p
WLNsPNtyMkVNVPE
Upstream
0 86
Treatment
  • IL-15
  • IL-2
ADD3 (human) WLNsPNtyMkVNVPE Y446-p
ADD3 iso2 (human) WLNSPNTYMKVNVPE Y446
ADD3 (mouse) WLNsPNTyMKVNVPE Y446-p
ADD3 iso2 (mouse) WLNSPNTYMKVNVPE Y446
ADD3 (rat) WLNSPNTYMKVNVPE Y446
K448-ub
NsPNtyMkVNVPEEs
0 1
ADD3 (human) NsPNtyMkVNVPEEs K448-ub
ADD3 iso2 (human) NSPNTYMKVNVPEES K448
ADD3 (mouse) NsPNTyMKVNVPEES K448
ADD3 iso2 (mouse) NSPNTYMKVNVPEES K448
ADD3 (rat) NSPNTYMKVNVPEES K448
S455-p
kVNVPEEsRNGEtsP
0 1
ADD3 (human) kVNVPEEsRNGEtsP S455-p
ADD3 iso2 (human) KVNVPEESRNGETSP S455
ADD3 (mouse) KVNVPEESRNGEtsP S455
ADD3 iso2 (mouse) KVNVPEESRNGETSP S455
ADD3 (rat) KVNVPEESRNGETSP S455
T460-p
EEsRNGEtsPRtKIt
0 3
ADD3 (human) EEsRNGEtsPRtKIt T460-p
ADD3 iso2 (human) EESRNGETSPRTKIT T460
ADD3 (mouse) EESRNGEtsPRtKIT T460-p
ADD3 iso2 (mouse) EESRNGETSPRTKIT T460
ADD3 (rat) EESRNGETSPRTKIT T460
S461-p
EsRNGEtsPRtKItW
0 17
ADD3 (human) EsRNGEtsPRtKItW S461-p
ADD3 iso2 (human) ESRNGETSPRTKITW S461
ADD3 (mouse) ESRNGEtsPRtKITW S461-p
ADD3 iso2 (mouse) ESRNGETSPRTKITW S461
ADD3 (rat) ESRNGETSPRTKITW S461
T464-p
NGEtsPRtKItWMKA
0 2
ADD3 (human) NGEtsPRtKItWMKA T464-p
ADD3 iso2 (human) NGETSPRTKITWMKA T464
ADD3 (mouse) NGEtsPRtKITWMKA T464-p
ADD3 iso2 (mouse) NGETSPRTKITWMKA T464
ADD3 (rat) NGETSPRTKITWMKA T464
T467-p
tsPRtKItWMKAEDS
0 1
ADD3 (human) tsPRtKItWMKAEDS T467-p
ADD3 iso2 (human) TSPRTKITWMKAEDS T467
ADD3 (mouse) tsPRtKITWMKAEDS T467
ADD3 iso2 (mouse) TSPRTKITWMKAEDS T467
ADD3 (rat) TSPRTKITWMKAEDP T467
S478-p
AEDSSKVsGGtPIKI
0 1
ADD3 (human) AEDSSKVsGGtPIKI S478-p
ADD3 iso2 (human) AEDSSKVSGGTPIKI S478
ADD3 (mouse) AEDSSKVSSGTPIkI S478
ADD3 iso2 (mouse) AEDSSKVSSGTPIKI S478
ADD3 (rat) AEDPSKVSSGTPIKI S478
T481-p
SSKVsGGtPIKIEDP
0 2
ADD3 (human) SSKVsGGtPIKIEDP T481-p
ADD3 iso2 (human) SSKVSGGTPIKIEDP T481
ADD3 (mouse) SSKVSSGTPIkIEDP T481
ADD3 iso2 (mouse) SSKVSSGTPIKIEDP T481
ADD3 (rat) PSKVSSGTPIKIEDP T481
K484
VsGGtPIKIEDPNQF
0 1
ADD3 (human) VsGGtPIKIEDPNQF K484
ADD3 iso2 (human) VSGGTPIKIEDPNQF K484
ADD3 (mouse) VSSGTPIkIEDPNQF K484-ub
ADD3 iso2 (mouse) VSSGTPIKIEDPNQF K484
ADD3 (rat) VSSGTPIKIEDPNQF K484
K504-ub
NPNEVLEkRNKIREQ
0 1
ADD3 (human) NPNEVLEkRNKIREQ K504-ub
ADD3 iso2 (human) NPNEVLEKRNKIREQ K504
ADD3 (mouse) NPTEVLEKRNKIREQ K504
ADD3 iso2 (mouse) NPTEVLEKRNKIREQ K504
ADD3 (rat) NPTEVLEKRNKIREQ K504
Y565-p
TEGELEEyKRTIERK
0 1
ADD3 (human) TEGELEEyKRTIERK Y565-p
ADD3 iso2 (human) TEGELEEYKRTIERK Y565
ADD3 (mouse) LEGELEEYTKTIERK Y565
ADD3 iso2 (mouse) LEGELEEYTKTIERk Y565
ADD3 (rat) MEGELEEYTKTIERQ Y565
K572
yKRTIERKQQGLEDA
0 1
ADD3 (human) yKRTIERKQQGLEDA K572
ADD3 iso2 (human) YKRTIERKQQGLEEN K572
ADD3 (mouse) YTKTIERKQQGLDDA K572
ADD3 iso2 (mouse) YTKTIERkQQGLDEN K572-ub
ADD3 (rat) YTKTIERQQQGLDDA Q572
L583
LEDAEQELLSDDASS
0 3
ADD3 (human) LEDAEQELLSDDASS L583
ADD3 iso2 (human) gap -
ADD3 (mouse) LDDAEQGsLsDDAAs S583-p
ADD3 iso2 (mouse) gap -
ADD3 (rat) LDDAEQEsLsDDAAS S583-p
S585
DAEQELLSDDASSVS
0 2
ADD3 (human) DAEQELLSDDASSVS S585
ADD3 iso2 (human) gap -
ADD3 (mouse) DAEQGsLsDDAAsVS S585-p
ADD3 iso2 (mouse) gap -
ADD3 (rat) DAEQEsLsDDAASVS S585-p
S590
LLSDDASSVSQIQSQ
0 1
ADD3 (human) LLSDDASSVSQIQSQ S590
ADD3 iso2 (human) gap -
ADD3 (mouse) sLsDDAAsVSQIQSQ S590-p
ADD3 iso2 (mouse) gap -
ADD3 (rat) sLsDDAASVSQIQSQ S590
S618-p
NHELFSKsFIsMEVP
0 3
ADD3 (human) NHELFSKsFIsMEVP S618-p
ADD3 iso2 (human) NHELFSKSFISMEVP S586
ADD3 (mouse) NHELFSKSFtsMDAP S618
ADD3 iso2 (mouse) NHELFSKSFTSMDAP S586
ADD3 (rat) NHELFSKSFTSVDVP S618
I620
ELFSKsFIsMEVPVM
0 1
ADD3 (human) ELFSKsFIsMEVPVM I620
ADD3 iso2 (human) ELFSKSFISMEVPVM I588
ADD3 (mouse) ELFSKSFtsMDAPVM T620-p
ADD3 iso2 (mouse) ELFSKSFTSMDAPVM T588
ADD3 (rat) ELFSKSFTSVDVPVI T620
S621-p
LFSKsFIsMEVPVMV
0 4
ADD3 (human) LFSKsFIsMEVPVMV S621-p
ADD3 iso2 (human) LFSKSFISMEVPVMV S589
ADD3 (mouse) LFSKSFtsMDAPVMI S621-p
ADD3 iso2 (mouse) LFSKSFTSMDAPVMI S589
ADD3 (rat) LFSKSFTSVDVPVIV S621
S647-p
DELAKRVsRLstsTt
0 2
ADD3 (human) DELAKRVsRLstsTt S647-p
ADD3 iso2 (human) DELAKRVSRLSTSTT S615
ADD3 (mouse) DELAQRVsRLttstt S647-p
ADD3 iso2 (mouse) DELAQRVSRLTTSTT S615
ADD3 (rat) DELAQRVSRLTTSTT S646
S650-p
AKRVsRLstsTtIEN
0 6
ADD3 (human) AKRVsRLstsTtIEN S650-p
ADD3 iso2 (human) AKRVSRLSTSTTIEN S618
ADD3 (mouse) AQRVsRLttsttIEN T650-p
ADD3 iso2 (mouse) AQRVSRLTTSTTIEN T618
ADD3 (rat) AQRVSRLTTSTTIEN T649
T651-p
KRVsRLstsTtIENI
0 4
ADD3 (human) KRVsRLstsTtIENI T651-p
ADD3 iso2 (human) KRVSRLSTSTTIENI T619
ADD3 (mouse) QRVsRLttsttIENI T651-p
ADD3 iso2 (mouse) QRVSRLTTSTTIENI T619
ADD3 (rat) QRVSRLTTSTTIENI T650
S652-p
RVsRLstsTtIENIE
0 3
ADD3 (human) RVsRLstsTtIENIE S652-p
ADD3 iso2 (human) RVSRLSTSTTIENIE S620
ADD3 (mouse) RVsRLttsttIENIE S652-p
ADD3 iso2 (mouse) RVSRLTTSTTIENIE S620
ADD3 (rat) RVSRLTTSTTIENIE S651
T653
VsRLstsTtIENIEI
0 1
ADD3 (human) VsRLstsTtIENIEI T653
ADD3 iso2 (human) VSRLSTSTTIENIEI T621
ADD3 (mouse) VsRLttsttIENIEI T653-p
ADD3 iso2 (mouse) VSRLTTSTTIENIEI T621
ADD3 (rat) VSRLTTSTTIENIEI T652
T654-p
sRLstsTtIENIEIT
0 8
ADD3 (human) sRLstsTtIENIEIT T654-p
ADD3 iso2 (human) SRLSTSTTIENIEIT T622
ADD3 (mouse) sRLttsttIENIEIT T654-p
ADD3 iso2 (mouse) SRLTTSTTIENIEIT T622
ADD3 (rat) SRLTTSTTIENIEIT T653
S673-p
EKIEEVLsPEGsPsK
Upstream
0 41
Treatment
  • dasatinib
ADD3 (human) EKIEEVLsPEGsPsK S673-p
ADD3 iso2 (human) EKIEEVLSPEGSPSK S641
ADD3 (mouse) ERTEEVLsPDGsPsK S673-p
ADD3 iso2 (mouse) ERTEEVLSPDGSPSK S641
ADD3 (rat) DRTEEVLsPDGsPSK S672-p
S677-p
EVLsPEGsPsKsPsK
Upstream
0 51
Treatment
  • dasatinib
  • ischemia
ADD3 (human) EVLsPEGsPsKsPsK S677-p
ADD3 iso2 (human) EVLSPEGSPSKSPSK S645
ADD3 (mouse) EVLsPDGsPsKsPsK S677-p
ADD3 iso2 (mouse) EVLSPDGSPSKSPSK S645
ADD3 (rat) EVLsPDGsPSKsPSK S676-p
S679-p
LsPEGsPsKsPsKKK
Upstream
0 24
Treatment
  • angiotensin_2
ADD3 (human) LsPEGsPsKsPsKKK S679-p
ADD3 iso2 (human) LSPEGSPSKSPSKKK S647
ADD3 (mouse) LsPDGsPsKsPsKKK S679-p
ADD3 iso2 (mouse) LSPDGSPSKSPSKKK S647
ADD3 (rat) LsPDGsPSKsPSKKK S678
S681-p
PEGsPsKsPsKKKKK
0 70
ADD3 (human) PEGsPsKsPsKKKKK S681-p
ADD3 iso2 (human) PEGSPSKSPSKKKKK S649
ADD3 (mouse) PDGsPsKsPsKKKKK S681-p
ADD3 iso2 (mouse) PDGSPSKSPSKKKKK S649
ADD3 (rat) PDGsPSKsPSKKKKK S680-p
S683-p
GsPsKsPsKKKKKFR
Upstream
0 28
Treatment
  • angiotensin_2
ADD3 (human) GsPsKsPsKKKKKFR S683-p
ADD3 iso2 (human) GSPSKSPSKKKKKFR S651
ADD3 (mouse) GsPsKsPsKKKKKFR S683-p
ADD3 iso2 (mouse) GSPSKSPSKKKKKFR S651
ADD3 (rat) GsPSKsPSKKKKKFR S682
T691-p
KKKKKFRtPsFLKKN
Upstream
0 31
Treatment
  • nocodazole
ADD3 (human) KKKKKFRtPsFLKKN T691-p
ADD3 iso2 (human) KKKKKFRTPSFLKKN T659
ADD3 (mouse) KKKKKFRtPsFLKKN T691-p
ADD3 iso2 (mouse) KKKKKFRTPSFLKKN T659
ADD3 (rat) KKKKKFRTPsFLKKN T690
S693-p
KKKFRtPsFLKKNKK
Upstream
1 219
Kinase, in vitro:
  • Chk1 (human)
Treatment
  • angiotensin_2
  • nocodazole
  • SII_angiotensin_2
ADD3 (human) KKKFRtPsFLKKNKK S693-p
ADD3 iso2 (human) KKKFRTPSFLKKNKK S661
ADD3 (mouse) KKKFRtPsFLKKNKK S693-p
ADD3 iso2 (mouse) KKKFRTPSFLKKNKK S661
ADD3 (rat) KKKFRTPsFLKKNKK S692-p